REFERENCES
- Bruno, R.; Matthews, A.J.; Dunn, M.; Alati, R.; McIlwraith, F.; Hickey, S.; Burns, L. & Sindicich, N. 2012. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug and Alcohol Dependence 124: 19–25.
- Burns, L.; Roxburgh, A.; Matthews, A.; Bruno, R.; Lenton, S. & Van, B.J. 2014. The rise of new psychoactive substance use in Australia. Drug Testing and Analysis 6: 846–849.
- Corazza, O.; Simonato, P.; Corkery, J.; Trincas, G. & Schifano, F. 2014. “Legal highs”: Safe and legal “heavens”? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Rivista di Psichiatria 49: 89–94.
- Dargan, P.I.; Albert, S. & Wood, D.M. 2010. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Quarterly Journal of Medicine 103: 875–879.
- EMCDDA. 2011. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances. Lisbon. Available at: http://www.emcdda.europa.eu/html.cfm/index116639EN.html.
- EMCDDA. 2014. European Drugs Report 2014: Trends and developments. Lisbon. Available at: http://www.emcdda.europa.eu/publications/edr/trends-developments/2014.
- Eurobarometer 2011. Youth attitudes on drugs. Analytical report. Flash EB Series #330. Available at: http://ec.europa.eu/public_opinion/archives/flash_arch_en.htm.
- Eurobarometer. 2014. Flash Eurobarometer 401. TNS political & social: Young people and drugs. Available at: http://ec.europa.eu/public_opinion/flash/fl_401_en.pdf.
- Gonzalez, D.; Ventura, M.; Caudevilla, F.; Torrens, M. & Farre, M. 2013. Consumption of new psychoactive substances in a Spanish sample of research chemical users. Human Psychopharmacology 28: 332–340.
- Kelleher, C.; Christie, R.; Lalor, K.; Fox, J.; Bowden, M. & O’Donnel, C. 2011. An overview of new psychoactive substances and the outlets supplying them. National Advisory Committee on Drugs. Available at: http://www.nacd.ie/publications/Head_Report2011_overview.pdf.
- McElrath, K. & O’Neill, C. 2011. Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. International Journal of Drug Policy 22: 120–127.
- Measham, F.; Moore, K.; Newcombe, R. & Welch, Z. 2010. Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today 10: 14–21.
- Miller, B.L.; Stogner, J.; Khey, D.N.; Akers, R.L.; Boman, J.H. & Griffin, O.H. 2011. Magic mint, the internet, and peer associations: A test of social learning theory using patterns of Salvia divinorum use. Journal of Drug Issues 41: 305–326.
- Moore, K.; Dargan, P.I.; Wood, D.M. & Measham, F. 2013. Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine. European Addiction Research 19: 276–282.
- Nabben, T.; Benschop, A. & Korf, D. 2014. Antenne 2013: Trends in Alcohol, Tabak en Drugs bij Jonge Amsterdammers. Amsterdam: Rozenberg Publishers. Available at: www.jellinek.nl/wp-content/uploads/2014/07/Antenne-2013.pdf
- Sindicich, N. & Burns, L. 2013. Australian trends in ecstacy and related drug markets 2012. Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trends Series No. 100. Available at: https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/EDRS%202012%20national%20report%20FINAL.pdf.
- Van Hout, M.C. & Bingham, T. 2013. “Surfing the Silk Road”: A study of users’ experiences. International Journal of Drug Policy 24: 524–529.
- Van Hout, M.C. & Brennan, R. 2011. “Heads held high”: An exploratory study of legal highs in pre-legislation Ireland. Journal of Ethnicity in Substance Abuse 10: 256–272.
- Vandrey, R.; Dunn, K.E.; Frey, J.A. & Girling, E.R. 2012. A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence 120: 238–241.
- Winstock, A.R. & Marsden, J. 2010. EMCDDA Technical report on mephedrone, Appendix 1 to Annex 1: Mephedrone: Assessment of health risks and harms. Available at: http://blekko.com/a/serpr?url=http%3A%2F%2Fwww.ofdt.fr%2FBDD%2Fpublications%2Fdocs%2FrarOEDTmephA1A1.pdf&i=NjVhMDRlNDdhM2FlZTE3NDc3ZGUyMWJhOWIyNmRjZDgsMTM1MDMzMDA2ODo5MjY4MWU&r=1.
- Winstock, A.R.; Marsden, J. & Mitcheson, L. 2010. What should be done about mephedrone? British Medical Journal 340: c1605.
- Wood, D.; Measham, F. & Dargan, P. 2012. “Our favourite drug”: Prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. Journal of Substance Use 17: 91–97.